Latest news
23-03-2022 - Psychiatry Consortium Call for Proposals: Novel Treatment Targets for Agitation in Dementia
The Psychiatry Consortium has launched a Call for Proposals for studies to investigate novel molecular drug targets for psychiatric symptoms of Alzheimer's disease, such as agitation, impulsivity, disinhibition, anxiety and aggression.
The Psychiatry Consortium is a strategic collaboration of medical research charities and pharmaceutical companies focusing on the challenge of identifying and validating novel drug targets to address the unmet therapeutic needs of people living with mental health conditions.
[...]